Get unlimited access to our best features
Subscribe now

Why Eli Lilly & Co could be a recession-proof stock - BitcoinEthereumNews.com

Summary by Ground News
Elly Lilly & Co. sales are expected to compound at a 9% annually to $45 billion by 2027. The shares are up almost 20% year-to-date (YTD) on steadily increasing trading volumes. On April 28, the company announced its Q1 2022 earnings results, beating analysts' estimates.
2 months ago

News Articles

More Filters
All
Left
Center
Right

Why Eli Lilly & Co could be a recession-proof stock - BitcoinEthereumNews.com

With inflation raging and the Federal Reserve (Fed) waging an epic battle against it, a recession seems on the horizon. Further, traders on Wall Street

2 months ago
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

No sources with tracked biases.
See less detail